Cardiovascular Diseases

A Novel Circulating MicroRNA for Myocarditis Diagnosis

A novel microRNA has been identified in mice and humans with myocarditis, and that the human homologue could be used to distinguish patients with myocarditis from those with myocardial infarction. The human homologue, designated hsa-miR-Chr8:96, was identified in four independent cohorts of patients with myocarditis. The area under the receiver-operating-characteristic curve for this novel microRNA for distinguishing patients with acute myocarditis from those with myocardial infarction was 0.927. The microRNA retained its diagnostic value in models after adjustment for age, sex, ejection fraction, and serum troponin level. The diagnosis of acute myocarditis typically requires either endomyocardial biopsy or cardiovascular magnetic resonance imaging. Source: https://www.nejm.org/

hyangiu

Recent Posts

Sugar-Sweetened Beverages and Fruit Juice in Youth Linked to Higher Risk of High BP Later in Life

Children and adolescents who regularly consume sugar-sweetened beverages (SSBs) and fruit juice may face a…

14 hours ago

Resistance Training Significantly Lowers CVD Risk in Women

Women who consistently performed resistance training had a substantially lower risk of major cardiovascular disease…

7 days ago

Intensive Lifestyle Intervention Reduces Long-Term Multimorbidity in Prediabetes

US Adults with prediabetes who participated in an intensive lifestyle intervention had a significantly lower…

1 week ago

Frailty Modifies the Relationship Between High BP and Dementia Risk in Older Adults

The impact of late-life high blood pressure (BP) on dementia risk appears to depend on…

1 week ago

Recombinant Shingles Vaccine Linked to Lower Dementia Risk

A U.S. study found that receiving the recombinant herpes zoster vaccine (RZV, shingles vaccine) was…

1 week ago

Sugar-Sweetened Beverages Linked to Higher Risk of Liver Cancer Subtypes

A pooled analysis of 11 prospective cohort studies involving more than 1.5 million adults found…

2 weeks ago

This website uses cookies.